Suppr超能文献

微小RNA-206通过靶向丝状肌动蛋白成核蛋白2在结直肠癌中发挥肿瘤抑制作用。

MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2.

作者信息

Ren X L, He G Y, Li X M, Men Hui, Yi L Z, Lu G F, Xin S N, Wu P X, Li Y L, Liao W T, Ding Y Q, Liang L

机构信息

Department of Pathology, Southern Medical University, Guangzhou City, 510515, Guangdong Province, People's Republic of China.

Guangdong Province Key Laboratory of Molecular Tumor Pathology, Guangzhou City, 510515, Guangdong Province, People's Republic of China.

出版信息

J Cancer Res Clin Oncol. 2016 Mar;142(3):581-92. doi: 10.1007/s00432-015-2053-8. Epub 2015 Oct 29.

Abstract

BACKGROUND

Colorectal cancer (CRC) is one of the most common cancers in the world. MicroRNAs play important roles in the progression of CRC. This study aimed to investigate the role of miR-206 and its novel mechanism in the invasion and metastasis of CRC.

METHODOLOGY

Real-time RT-PCR or Western blotting was used to detect the expressions of miR-206, FMNL2 and c-MET in CRC cell lines and tissues. Luciferase reporter assays were conducted to detect the associations between miR-206 and 3'UTRs of FMNL2 and c-MET. A series of loss-of-function and gain-of-function assays were performed to evaluate the effect of miR-206 on the proliferation, invasion and metastasis of CRC cells.

RESULTS

miR-206 was significantly down-regulated in CRC tissues and correlated closely with differentiation, lymphatic metastasis and serosal invasion. miR-206 suppressed CRC cell proliferation by arresting CRC cells in the G1/G0 phase and accelerating apoptosis. miR-206 also inhibited cell invasion and lung metastasis in CRC cells. Mechanically, FMNL2 and c-MET were identified as direct targets of miR-206. And FMNL2 rescued the suppression of miR-206 in the proliferation and invasion of CRC cells.

CONCLUSIONS

This study revealed functional and mechanistic links between miR-206 and oncogene FMNL2 and c-MET in the progression of CRC. miR-206 functioned as a tumor suppressor in the progression of CRC by targeting FMNL2 and c-MET. Restoration of miR-206 expression may represent a promising therapeutic approach for targeting malignant CRC.

摘要

背景

结直肠癌(CRC)是世界上最常见的癌症之一。微小RNA在结直肠癌的进展中起重要作用。本研究旨在探讨miR-206在结直肠癌侵袭和转移中的作用及其新机制。

方法

采用实时逆转录聚合酶链反应(RT-PCR)或蛋白质免疫印迹法检测结直肠癌细胞系和组织中miR-206、丝状肌动蛋白成核因子样蛋白2(FMNL2)和肝细胞生长因子受体(c-MET)的表达。进行荧光素酶报告基因检测以检测miR-206与FMNL2和c-MET的3'非翻译区(3'UTR)之间的关联。进行一系列功能缺失和功能获得实验以评估miR-206对结直肠癌细胞增殖、侵袭和转移的影响。

结果

miR-206在结直肠癌组织中显著下调,且与分化、淋巴转移和浆膜侵犯密切相关。miR-206通过使结直肠癌细胞停滞于G1/G0期并加速凋亡来抑制其增殖。miR-206还抑制结直肠癌细胞的侵袭和肺转移。机制上,FMNL2和c-MET被确定为miR-206的直接靶点。并且FMNL2挽救了miR-206对结直肠癌细胞增殖和侵袭的抑制作用。

结论

本研究揭示了miR-206与癌基因FMNL2和c-MET在结直肠癌进展中的功能和机制联系。miR-206通过靶向FMNL2和c-MET在结直肠癌进展中发挥肿瘤抑制作用。恢复miR-206的表达可能是一种有前景的针对恶性结直肠癌的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验